Micro Labs And Zydus Deal Quickly From Tofacitinib Action
Indian ANDA Sponsors Sued By Pfizer Over Xeljanz Earlier This Year
Hatch-Waxman cases filed by Pfizer against Micro Labs and Zydus Cadila over generic versions of Pfizer’s Xeljanz/Xeljanz XR will not move to trial, following settlement agreements covering two patents expiring in March 2023 and December 2025.
